375 related articles for article (PubMed ID: 26325320)
21. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
[TBL] [Abstract][Full Text] [Related]
22. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude.
Yan G; Xu Q; Anissimov YG; Hao J; Higuchi WI; Li SK
Pharm Res; 2008 Mar; 25(3):616-24. PubMed ID: 17703345
[TBL] [Abstract][Full Text] [Related]
23. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
24. SLN and NLC for topical, dermal, and transdermal drug delivery.
Souto EB; Baldim I; Oliveira WP; Rao R; Yadav N; Gama FM; Mahant S
Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958
[No Abstract] [Full Text] [Related]
25. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures.
Singh P; Roberts MS
J Pharm Sci; 1993 Feb; 82(2):127-31. PubMed ID: 8445523
[TBL] [Abstract][Full Text] [Related]
26. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
27. Acyclovir skin depot characterization following in vivo iontophoretic delivery.
Siddoju S; Sachdeva V; Friden PM; Yu YY; Banga AK
Skin Res Technol; 2011 May; 17(2):234-44. PubMed ID: 21272079
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of Nanostructured Lipid Carriers (NLC)-Based Gels from Microemulsion Template for Delivery Through Skin.
Joshi MD; Prabhu RH; Patravale VB
Methods Mol Biol; 2019; 2000():279-292. PubMed ID: 31148022
[TBL] [Abstract][Full Text] [Related]
30. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
[TBL] [Abstract][Full Text] [Related]
31. Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles.
Taveira SF; De Santana DC; Araújo LM; Marquele-Oliveira F; Nomizo A; Lopez RF
J Biomed Nanotechnol; 2014 Jul; 10(7):1382-90. PubMed ID: 24804558
[TBL] [Abstract][Full Text] [Related]
32. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
33. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
[TBL] [Abstract][Full Text] [Related]
34. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
35. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
[TBL] [Abstract][Full Text] [Related]
36. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
[TBL] [Abstract][Full Text] [Related]
37. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
Suter F; Schmid D; Wandrey F; Zülli F
Eur J Pharm Biopharm; 2016 Nov; 108():304-309. PubMed ID: 27343822
[TBL] [Abstract][Full Text] [Related]
38. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
Juluri A; Narasimha Murthy S
J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
[TBL] [Abstract][Full Text] [Related]
39. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
40. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
Juluri A; Peddikotla P; Repka MA; Murthy SN
J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
